{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:06:20Z","timestamp":1783112780374,"version":"3.54.6"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401674"],"award-info":[{"award-number":["82401674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01626-1","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:36:49Z","timestamp":1763127409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fc-Modified IVIG with Enhanced Blood\u2013Brain Barrier Penetration Ameliorates Cognitive Deficits and Neuropathology in A53T \u03b1-Synuclein Transgenic Mice"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-0471","authenticated-orcid":false,"given":"Jie","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-7116","authenticated-orcid":false,"given":"Ya-ru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2972-0832","authenticated-orcid":false,"given":"Mei-qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2683-7668","authenticated-orcid":false,"given":"Shi-yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-4375","authenticated-orcid":false,"given":"Xiao-lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-4968","authenticated-orcid":false,"given":"Gui-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5313-9714","authenticated-orcid":false,"given":"Rui-tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"6","key":"1626_CR1","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1039\/d1ra08131d","volume":"12","author":"Y Anami","year":"2022","unstructured":"Anami Y, Xiong W, Yamaguchi A, Yamazaki CM, Zhang N, An Z, Tsuchikama K (2022) Homogeneous antibody\u2013Angiopep-2 conjugates for effective brain targeting. RSC Adv 12(6):3359\u20133364. https:\/\/doi.org\/10.1039\/d1ra08131d","journal-title":"RSC Adv"},{"issue":"19","key":"1626_CR2","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.3390\/molecules25194382","volume":"25","author":"S Aryal","year":"2020","unstructured":"Aryal S, Skinner T, Bridges B, Weber JT (2020) The pathology of Parkinson\u2019s disease and potential benefit of dietary polyphenols. Molecules 25(19):4382. https:\/\/doi.org\/10.3390\/molecules25194382","journal-title":"Molecules"},{"issue":"1","key":"1626_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.expneurol.2012.07.022","volume":"238","author":"F Bard","year":"2012","unstructured":"Bard F, Fox M, Friedrich S, Seubert P, Schenk D, Kinney GG, Yednock T (2012) Sustained levels of antibodies against A\u03b2 in amyloid-rich regions of the CNS. Exp Neurol 238(1):38\u201343. https:\/\/doi.org\/10.1016\/j.expneurol.2012.07.022","journal-title":"Exp Neurol"},{"issue":"6","key":"1626_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1590\/0004-282X20150057","volume":"73","author":"TB Bassani","year":"2015","unstructured":"Bassani TB, Vital MA, Rauh LK (2015) Neuroinflammation in the pathophysiology of Parkinson\u2019s disease and therapeutic evidence of anti-inflammatory drugs. Arq Neuropsiquiatr 73(6):516\u2013524. https:\/\/doi.org\/10.1590\/0004-282X20150057","journal-title":"Arq Neuropsiquiatr"},{"issue":"8","key":"1626_CR5","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.jaip.2023.04.002","volume":"11","author":"J Bayry","year":"2023","unstructured":"Bayry J, Ahmed EA, Toscano-Rivero D, Vonniessen N, Genest G, Cohen CG, Dembele M, Kaveri SV, Mazer BD (2023) Intravenous immunoglobulin: Mechanism of action in autoimmune and inflammatory diseases. J Allergy Clin Immunol 11(8), 2365\u20132376. https:\/\/doi.org\/10.1016\/j.jaip.2023.04.002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1626_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2144\/000113382","volume":"48","author":"J Bordeaux","year":"2010","unstructured":"Bordeaux J, Welsh AW, Agarwal S, Killiam E, Baquero MT, Hanna JA, Anagnostou VK, Rimm DL (2010) Antibody validation. Biotechniques 48(3):197\u2013209. https:\/\/doi.org\/10.2144\/000113382","journal-title":"Biotechniques"},{"issue":"1","key":"1626_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(1):417. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"issue":"4","key":"1626_CR8","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","volume":"106","author":"M Demeule","year":"2008","unstructured":"Demeule M, Currie JC, Bertrand Y, Ch\u00e9 C, Nguyen T, R\u00e9gina A, Gabathuler R, Castaigne JP, B\u00e9liveau R (2008) Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2. J Neurochem 106(4):1534\u20131544. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05492.x","journal-title":"J Neurochem"},{"issue":"19","key":"1626_CR9","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.3390\/molecules27196696","volume":"27","author":"AC di Polidoro","year":"2022","unstructured":"di Polidoro AC, Cafarchio A, Vecchione D, Donato P, De Nola F, Torino E (2022) Revealing Angiopep-2\/LRP1 molecular interaction for optimal delivery to glioblastoma. Molecules 27(19):6696. https:\/\/doi.org\/10.3390\/molecules27196696","journal-title":"Molecules"},{"issue":"1","key":"1626_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4049\/jimmunol.1701093","volume":"201","author":"\u00c1 Dom\u00ednguez-Soto","year":"2018","unstructured":"Dom\u00ednguez-Soto \u00c1, Sim\u00f3n-Fuentes M, de Las Casas-Engel M, Cuevas VD, L\u00f3pez-Bravo M, Dom\u00ednguez-Andr\u00e9s J, Saz-Leal P, Sancho D, Ardav\u00edn C, Ochoa-Grull\u00f3n J, S\u00e1nchez-Ram\u00f3n S, Vega MA, Corb\u00ed AL (2018) IVIg promotes cross-tolerance against inflammatory stimuli in vitro and in vivo. J Immunol 201(1):41\u201352. https:\/\/doi.org\/10.4049\/jimmunol.1701093","journal-title":"J Immunol"},{"issue":"51","key":"1626_CR11","doi-asserted-by":"publisher","first-page":"32691","DOI":"10.1073\/pnas.2014449117","volume":"117","author":"S Dubey","year":"2020","unstructured":"Dubey S, Heinen S, Krantic S, McLaurin J, Branch DR, Hynynen K, Aubert I (2020) Clinically approved IVIg delivered to the hippocampus with focused ultrasound. Proc Natl Acad Sci USA 117(51):32691\u201332700. https:\/\/doi.org\/10.1073\/pnas.2014449117","journal-title":"Proc Natl Acad Sci USA"},{"key":"1626_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z, Dakin HA, Sideris DI, Lam J, Ranasinghe RT, Kouli A, Zhao Y, De S, Knowles TPJ, Vendruscolo M, Ruggeri FS, Aigbirhio FI, Williams-Gray CH, Klenerman D (2022) Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun 13:5301. https:\/\/doi.org\/10.1038\/s41467-022-33252-6","journal-title":"Nat Commun"},{"issue":"2","key":"1626_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/biom12020168","volume":"12","author":"J Folke","year":"2022","unstructured":"Folke J, Ferreira N, Brudek T, Borghammer P, Van Den Berge N (2022) Passive immunization in alpha-synuclein preclinical animal models. Biomolecules 12(2):168. https:\/\/doi.org\/10.3390\/biom12020168","journal-title":"Biomolecules"},{"key":"1626_CR14","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.1038\/s41598-023-41382-0","volume":"13","author":"H Geerts","year":"2023","unstructured":"Geerts H, Bergeler S, Walker M, van der Graaf PH, Courade JP (2023) Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model. Sci Rep 13:12421. https:\/\/doi.org\/10.1038\/s41598-023-41382-0","journal-title":"Sci Rep"},{"issue":"1","key":"1626_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biologicals.2010.11.002","volume":"39","author":"T Georgakopoulos","year":"2011","unstructured":"Georgakopoulos T, Tatford OC, Gurevich V, Bertolini J (2011) C1q aggregate binding for the determination of anti-complementary activity of immunoglobulin preparations. Biologicals 39(1):38\u201342. https:\/\/doi.org\/10.1016\/j.biologicals.2010.11.002","journal-title":"Biologicals"},{"issue":"4","key":"1626_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","volume":"6","author":"JV Georgieva","year":"2014","unstructured":"Georgieva JV, Hoekstra D, Zuhorn IS (2014) Smuggling drugs into the brain: an overview of ligands targeting transcytosis. Pharmaceutics 6(4):557\u2013583. https:\/\/doi.org\/10.3390\/pharmaceutics6040557","journal-title":"Pharmaceutics"},{"issue":"4","key":"1626_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM-Y (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34(4):521\u2013533. https:\/\/doi.org\/10.1016\/S0896-6273(02)00682-7","journal-title":"Neuron"},{"issue":"9","key":"1626_CR18","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.3390\/ijms23094508","volume":"23","author":"E Guatteo","year":"2022","unstructured":"Guatteo E, Berretta N, Monda V, Ledonne A, Mercuri NB (2022) Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson\u2019s disease. Int J Mol Sci 23(9):4508. https:\/\/doi.org\/10.3390\/ijms23094508","journal-title":"Int J Mol Sci"},{"key":"1626_CR19","doi-asserted-by":"publisher","DOI":"10.3791\/1787","volume":"39","author":"SJ Guyenet","year":"2010","unstructured":"Guyenet SJ, Furrer VM, Damian TD, Baughan AR, La Spada GA, Garden GA (2010) A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp 39:e1787. https:\/\/doi.org\/10.3791\/1787","journal-title":"J Vis Exp"},{"issue":"4","key":"1626_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/polym14040712","volume":"14","author":"S Habib","year":"2022","unstructured":"Habib S, Singh M (2022) Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: a review. Polymers 14(4):712. https:\/\/doi.org\/10.3390\/polym14040712","journal-title":"Polymers"},{"key":"1626_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2018.11.024","volume":"124","author":"YR Huang","year":"2019","unstructured":"Huang YR, Xie XX, Ji M, Yu XL, Zhu J, Zhang LX, Liu XG, Wei C, Li G, Liu RT (2019) Naturally occurring autoantibodies against \u03b1-synuclein rescue memory and motor deficits and attenuate \u03b1-synuclein pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 124:297\u2013306. https:\/\/doi.org\/10.1016\/j.nbd.2018.11.024","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1626_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/ani9100754","volume":"9","author":"RC Hubrecht","year":"2019","unstructured":"Hubrecht RC, Carter E (2019) The 3Rs and humane experimental technique: implementing change. Animals 9(10):754. https:\/\/doi.org\/10.3390\/ani9100754","journal-title":"Animals"},{"key":"1626_CR23","unstructured":"National Institutes of Health. Reminder: Authentication of Key Biological and\/or Chemical Resources. Notice Number NOT-OD-17\u2013068; 2017\u201305\u201331. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-OD-17-068.html"},{"issue":"7","key":"1626_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia-mediated neuroinflammation in Parkinson\u2019s disease. Cells 12(7):1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"issue":"11","key":"1626_CR25","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1007\/s11095-014-1596-8","volume":"32","author":"T Kline","year":"2015","unstructured":"Kline T, Steiner AR, Penta K, Sato AK, Hallam TJ, Yin G (2015) Methods to make homogenous antibody\u2013drug conjugates. Pharm Res 32(11):3480\u20133493. https:\/\/doi.org\/10.1007\/s11095-014-1596-8","journal-title":"Pharm Res"},{"key":"1626_CR26","doi-asserted-by":"publisher","first-page":"1257973","DOI":"10.3389\/fnagi.2023.1257973","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Wu X, Tan X, Wang S, Qu R, Wu X, Chen Z, Wang Z, Chen G (2023) The efficacy and safety of anti-A\u03b2 agents for delaying cognitive decline in Alzheimer\u2019s disease: a meta-analysis. Front Aging Neurosci 15:1257973. https:\/\/doi.org\/10.3389\/fnagi.2023.1257973","journal-title":"Front Aging Neurosci"},{"issue":"7638","key":"1626_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"issue":"1","key":"1626_CR28","first-page":"31","volume":"62","author":"DA Loeffler","year":"2012","unstructured":"Loeffler DA, Smith LM, Klaver AC, Brzezinski HA, Morrison EI, Coffey MP, Steficek BA, Cook SS (2012) Development of anti-human IgG antibodies and hematologic deficits but not clinical disease in rhesus macaques. Comp Med 62(1):31\u201336","journal-title":"Comp Med"},{"key":"1626_CR29","doi-asserted-by":"publisher","DOI":"10.3791\/55718","volume":"126","author":"LM Lueptow","year":"2017","unstructured":"Lueptow LM (2017) Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp 126:e55718. https:\/\/doi.org\/10.3791\/55718","journal-title":"J Vis Exp"},{"issue":"1","key":"1626_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","volume":"26","author":"LJ Martin","year":"2006","unstructured":"Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK (2006) Parkinson\u2019s disease \u03b1-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26(1):41\u201350. https:\/\/doi.org\/10.1523\/JNEUROSCI.4308-05.2006","journal-title":"J Neurosci"},{"issue":"2","key":"1626_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antiox12020517","volume":"12","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD (2023) Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants 12(2):517. https:\/\/doi.org\/10.3390\/antiox12020517","journal-title":"Antioxidants"},{"key":"1626_CR32","doi-asserted-by":"publisher","first-page":"1227816","DOI":"10.3389\/fddev.2023.1227816","volume":"3","author":"WM Pardridge","year":"2023","unstructured":"Pardridge WM (2023) Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood\u2013brain barrier. Front Drug Del 3:1227816. https:\/\/doi.org\/10.3389\/fddev.2023.1227816","journal-title":"Front Drug Del"},{"key":"1626_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105789","volume":"164","author":"JE Pestana","year":"2024","unstructured":"Pestana JE, Graham BM (2024) The impact of estrous cycle on anxiety-like behaviour during unlearned fear tests in female rats and mice: a systematic review and meta-analysis. Neurosci Biobehav Rev 164:105789. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105789","journal-title":"Neurosci Biobehav Rev"},{"key":"1626_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2019.04.004","volume":"703","author":"M Rabenstein","year":"2019","unstructured":"Rabenstein M, Besong Agbo D, Wolf E, Dams J, Nicolai M, Roeder A, Bacher M, Dodel RC, Noelker C (2019) Effect of naturally occurring \u03b1-synuclein-antibodies on toxic \u03b1-synuclein fragments. Neurosci Lett 703:78\u201383. https:\/\/doi.org\/10.1016\/j.neulet.2019.04.004","journal-title":"Neurosci Lett"},{"issue":"2","key":"1626_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","volume":"189","author":"H Shiotsuki","year":"2010","unstructured":"Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu K, Ikeda R, Takahashi R, Kitazawa S, Hattori N (2010) A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189(2):180\u2013185. https:\/\/doi.org\/10.1016\/j.jneumeth.2010.03.026","journal-title":"J Neurosci Methods"},{"issue":"2","key":"1626_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaci.2020.06.036","volume":"146","author":"A Shock","year":"2020","unstructured":"Shock A, Humphreys D, Nimmerjahn F (2020) Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fc\u03b3 receptors. J Allergy Clin Immunol 146(2):262\u2013265. https:\/\/doi.org\/10.1016\/j.jaci.2020.06.036","journal-title":"J Allergy Clin Immunol"},{"key":"1626_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1742-2094-9-234","volume":"9","author":"I St-Amour","year":"2012","unstructured":"St-Amour I, Bousquet M, Par\u00e9 I, Drouin-Ouellet J, Cicchetti F, Bazin R, Calon F (2012) Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson\u2019s disease. J Neuroinflam 9:234. https:\/\/doi.org\/10.1186\/1742-2094-9-234","journal-title":"J Neuroinflam"},{"issue":"12","key":"1626_CR38","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour I, Par\u00e9 I, Alata W, Coulombe K, Ringuette-Goulet C, Drouin-Ouellet J, Vandal M, Soulet D, Bazin R, Calon F (2013) Brain bioavailability of human intravenous immunoglobulin and its transport mechanisms. J Cereb Blood Flow Metab 33(12):1983\u20131992. https:\/\/doi.org\/10.1038\/jcbfm.2013.160","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"1626_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"key":"1626_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s42003-025-07680-1","volume":"8","author":"S Tullo","year":"2025","unstructured":"Tullo S, Park JSH, Gallino D, Park M, Mar K, Novikov V, Sandoval Contreras R, Patel R, del Cid-Pellitero E, Fon EA, Luo W, Shlaifer I, Durcan TM, Prado MAM, Prado VF, Devenyi GA, Chakravarty MM (2025) Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils. Commun Biol 8:288. https:\/\/doi.org\/10.1038\/s42003-025-07680-1","journal-title":"Commun Biol"},{"issue":"10","key":"1626_CR41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nmeth.3995","volume":"13","author":"M Uhlen","year":"2016","unstructured":"Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, Yamamoto T (2016) A proposal for validation of antibodies. Nat Methods 13(10):823\u2013827. https:\/\/doi.org\/10.1038\/nmeth.3995","journal-title":"Nat Methods"},{"key":"1626_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2016.02.015","volume":"105","author":"T Wang","year":"2016","unstructured":"Wang T, Xie XX, Ji M, Yu XL, Zhu J, Zhou WW, Wei C, Ma S, Xi ZY, Pang GL, Liu RT (2016) Naturally occurring autoantibodies against A\u03b2 oligomers exhibited more beneficial effects in the treatment of a mouse model of Alzheimer\u2019s disease than intravenous immunoglobulin. Neuropharmacology 105:561\u2013569. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.015","journal-title":"Neuropharmacology"},{"issue":"7","key":"1626_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307012","volume":"19","author":"K Wang","year":"2024","unstructured":"Wang K, Han C, Yang J, Xu W, Wang L, Li H, Wang Y (2024) Benfotiamine protects against MPTP-induced Parkinson\u2019s disease in a mouse model via activation of the Nrf2 pathway. PLoS ONE 19(7):e0307012. https:\/\/doi.org\/10.1371\/journal.pone.0307012","journal-title":"PLoS ONE"},{"issue":"12","key":"1626_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260954","volume":"16","author":"I Wilkinson","year":"2021","unstructured":"Wilkinson I, Anderson S, Fry J, Julien LA, Neville D, Qureshi O, Watts G, Hale G (2021) Fc-engineered antibodies with immune effector functions completely abolished. PLoS ONE 16(12):e0260954. https:\/\/doi.org\/10.1371\/journal.pone.0260954","journal-title":"PLoS ONE"},{"key":"1626_CR45","unstructured":"World Health Organization (2022, June 14) Parkinson disease: A public health approach (Technical brief; ISBN: 978\u201392\u20134\u2013005098\u20133). https:\/\/www.who.int\/publications\/i\/item\/9789240050983"},{"key":"1626_CR46","unstructured":"World Health Organization (2023, August 9) Parkinson disease (Fact sheet). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease"},{"issue":"4","key":"1626_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/antib12040071","volume":"12","author":"Q Yang","year":"2023","unstructured":"Yang Q, Chen H, Ou C, Zheng Z, Zhang X, Liu Y, Zong GX, Wang LX (2023) Evaluation of two chemoenzymatic glycan remodeling approaches to generate site-specific antibody\u2013drug conjugates. Antibodies 12(4):71. https:\/\/doi.org\/10.3390\/antib12040071","journal-title":"Antibodies"},{"key":"1626_CR48","doi-asserted-by":"publisher","first-page":"36631","DOI":"10.1038\/srep36631","volume":"6","author":"J Zha","year":"2016","unstructured":"Zha J, Liu X-M, Zhu J, Liu S-Y, Lu S, Xu P-X, Yu X-L, Liu R-T (2016) A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses. Sci Rep 6:36631. https:\/\/doi.org\/10.1038\/srep36631","journal-title":"Sci Rep"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:24:34Z","timestamp":1765535074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01626-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7354381\/v1","asserted-by":"object"}]},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with the China Public Health Service Guide for the Care and Use of Laboratory Animals. The animal study protocol was approved by the Institutional Animal Care and Use Committee of the Institute of Process Engineering, Chinese Academy of Sciences (Approval code: IPEAECA2022068; Approval date: 1 December 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"103"}}